Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas

Wouter Froyman; Chiara Landolfo; Frédéric Amant; Thierry van den Bosch; Ignace Vergote; An Coosemans; Antonia Testa; Lil Valentin; Tom Bourne; Ben van Calster; Dirk Timmerman

doi:https://doi.org/10.1016/S1470-2045(16)00022-X

Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas

Wouter Froyman, Chiara Landolfo, Frédéric Amant, Thierry van den Bosch, Ignace Vergote, An Coosemans, Antonia Testa, Lil Valentin, Tom Bourne, Ben van Calster, Dirk Timmerman

Other Departments

Research output: Contribution to journal › Editorial › Academic › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	273-274
Journal	lancet oncology
Volume	17
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(16)00022-X
Publication status	Published - 2016

Access to Document

https://doi.org/10.1016/S1470-2045(16)00022-X

Cite this

@article{2aa040bdd5b449fe8ddc72350dd6632b,

title = "Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas",

author = "Wouter Froyman and Chiara Landolfo and Fr{\'e}d{\'e}ric Amant and {van den Bosch}, Thierry and Ignace Vergote and An Coosemans and Antonia Testa and Lil Valentin and Tom Bourne and {van Calster}, Ben and Dirk Timmerman",

year = "2016",

doi = "https://doi.org/10.1016/S1470-2045(16)00022-X",

language = "English",

volume = "17",

pages = "273--274",

journal = "lancet oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "3",

}

TY - JOUR

T1 - Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas

AU - Froyman, Wouter

AU - Landolfo, Chiara

AU - Amant, Frédéric

AU - van den Bosch, Thierry

AU - Vergote, Ignace

AU - Coosemans, An

AU - Testa, Antonia

AU - Valentin, Lil

AU - Bourne, Tom

AU - van Calster, Ben

AU - Timmerman, Dirk

PY - 2016

Y1 - 2016

U2 - https://doi.org/10.1016/S1470-2045(16)00022-X

DO - https://doi.org/10.1016/S1470-2045(16)00022-X

M3 - Editorial

C2 - 26972853

SN - 1470-2045

VL - 17

SP - 273

EP - 274

JO - lancet oncology

JF - lancet oncology

IS - 3

ER -